問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Chung Shan Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-11-01 - 2027-10-11
Condition/Disease
Systemic lupus erythematosus
Test Drug
DB-2304
Participate Sites4Sites
Recruiting4Sites
2025-11-19 - 2030-06-30
Platinum-based therapy-resistant epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer
Navicixizumab
Participate Sites10Sites
Recruiting10Sites
2024-07-01 - 2030-12-31
Participate Sites2Sites
Recruiting2Sites
2025-08-01 - 2031-12-31
Participate Sites7Sites
Recruiting7Sites
2026-03-30 - 2027-12-31
Participate Sites3Sites
Recruiting3Sites
2024-02-01 - 2026-07-27
Participate Sites5Sites
Recruiting5Sites
2023-04-01 - 2031-12-31
2023-03-01 - 2026-12-31
2024-05-31 - 2027-05-31
2022-11-01 - 2028-12-31
全部
